SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-20-020529
Filing Date
2020-11-05
Accepted
2020-11-05 07:24:36
Documents
61
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 1488042
2 ex31-1.htm EX-31.1 18375
3 ex31-2.htm EX-31.2 18602
4 ex32-1.htm EX-32.1 6380
5 ex32-2.htm EX-32.2 6601
  Complete submission text file 0001493152-20-020529.txt   5270760

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE prvb-20200930.xsd EX-101.SCH 37986
7 XBRL CALCULATION FILE prvb-20200930_cal.xml EX-101.CAL 38908
8 XBRL DEFINITION FILE prvb-20200930_def.xml EX-101.DEF 135855
9 XBRL LABEL FILE prvb-20200930_lab.xml EX-101.LAB 302075
10 XBRL PRESENTATION FILE prvb-20200930_pre.xml EX-101.PRE 232741
11 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 770625
Mailing Address 55 BROAD STREET, 2ND FLOOR RED BANK NJ 07701
Business Address 55 BROAD STREET, 2ND FLOOR RED BANK NJ 07701 908-428-9136
Provention Bio, Inc. (Filer) CIK: 0001695357 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38552 | Film No.: 201288678
SIC: 2834 Pharmaceutical Preparations